Roche problems in UK threaten wide range of tests, treatments - biomedical body
Reuters
Published Oct 07, 2020 11:08
Updated Oct 07, 2020 11:45
LONDON (Reuters) - A logistics failure at a Roche (S:ROG) facility in England has caused deliveries of materials used in tests for COVID and other conditions not to take place, and problems could escalate, the head of a professional biomedical body said on Wednesday.
Roche said earlier it regretted that there had been delays in dispatching some products and these were due to unforeseen problems at a new distribution centre.
Allan Wilson, head of the Institute of Biomedical Science, said problems with supplies from Roche had started to emerge about a week ago and were affecting not only COVID tests but also diagnostic and treatment materials for other conditions.
"The frustration is that they seem to have a warehouse full of consumables but are unable to ship them because the logistics system put in place to manage the extraction and identification of consumables and picking them to send them to customers has failed," Wilson told Reuters in a telephone interview.
Get The App
Written By: Reuters
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.